Nine Entos Team members among the #COVIDisAirborne team that is selected as Gordon Bell Finalists and featured in The New York Times
Entos selected by Forbes Magazine for 2022 list of groundbreaking artificial intelligence companies
Nick brings 35 years of R&D experience across a broad spectrum of therapeutic areas and modalities
A statement from the Entos management team and Board of directors in memoriam of Naren Gupta